ReP USP - Resultado da busca

Artigo de periodico
Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants (2025)
Daher, Isabela Pazotti ; Almeida, Bianca da Silva ; Souza-Silva, Guilherme Antonio de ; Marques, Rodolfo Ferreira ; Soares, Gustavo Henrique Corrêa ; Andreata-Santos, Robert ; Moretti, Ana ; Silva, Mariângela de Oliveira ; Schuch, Viviane ; Sasahara, Greyce Luri ; Kuramoto, Andréia; Yamamoto, Márcio ; Santos, Keity ; Coelho, Veronica Porto Carreiro de Vasconcellos ; Kalil Filho, Jorge Elias ; Rosa, Daniela Santoro ; Cunha Neto, Edecio ; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Clinical Immunology. Unidades: ICB, FM, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, VARIAÇÃO GENÉTICA, COVID-19, VACINAS VIRAIS, NEUTRALIZAÇÃO, CORONAVIRUS, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAHER, Isabela Pazotti et al. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, v. 276, p. 12 , 2025Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2025.110492. Acesso em: 01 jul. 2025.
APA
Daher, I. P., Almeida, B. da S., Souza-Silva, G. A. de, Marques, R. F., Soares, G. H. C., Andreata-Santos, R., et al. (2025). Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants. Clinical Immunology, 276, 12 . doi:10.1016/j.clim.2025.110492
NLM
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2025.110492
Vancouver
Daher IP, Almeida B da S, Souza-Silva GA de, Marques RF, Soares GHC, Andreata-Santos R, Moretti A, Silva M de O, Schuch V, Sasahara GL, Kuramoto A, Yamamoto M, Santos K, Coelho VPC de V, Kalil Filho JE, Rosa DS, Cunha Neto E, Ferreira LC de S, Boscardin SB. Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: differential neutralization of SARS-CoV-2 omicron variants [Internet]. Clinical Immunology. 2025 ; 276 12 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2025.110492
Artigo de periodico
What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience (2024)
Mendonça, Leonardo; Pontillo, Alessandra ; Freschi-Barros, Samar; Melato, Amanda; Cunha, Ana Luiza; Ianhez, Mayra; Osaku, Fabiane; Carvalho, Luciana Martins de ; Didier, Felipe; Cavalcanti, Andre; Carlos, Luana Ribeiro; Takano, Olga Akiko ; Robazzi, Tereza; Alcantara, Carolina; Francescantonio, Isadora; Frèmond, Marie-Louise; Kalil Filho, Jorge Elias
Source: Clinical Immunology. Conference titles: Selected Abstracts from the 2024 Clinical Immunology Society Annual Meeting: Immune Deficiency and Dysregulation North American Conference. Unidades: ICB, FMRP, FM
Subjects: IMUNOLOGIA, INFLAMAÇÃO, GENÔMICA, SEQUENCIAMENTO GENÉTICO, DOENÇAS GENÉTICAS, SISTEMA IMUNE, TESTES IMUNOLÓGICOS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Leonardo et al. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience. Clinical Immunology, v. 262, p. 51-52, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2024.110132. Acesso em: 01 jul. 2025.
APA
Mendonça, L., Pontillo, A., Freschi-Barros, S., Melato, A., Cunha, A. L., Ianhez, M., et al. (2024). What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience. Clinical Immunology, 262, 51-52. doi:10.1016/j.clim.2024.110132
NLM
Mendonça L, Pontillo A, Freschi-Barros S, Melato A, Cunha AL, Ianhez M, Osaku F, Carvalho LM de, Didier F, Cavalcanti A, Carlos LR, Takano OA, Robazzi T, Alcantara C, Francescantonio I, Frèmond M-L, Kalil Filho JE. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience [Internet]. Clinical Immunology. 2024 ; 262 51-52.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2024.110132
Vancouver
Mendonça L, Pontillo A, Freschi-Barros S, Melato A, Cunha AL, Ianhez M, Osaku F, Carvalho LM de, Didier F, Cavalcanti A, Carlos LR, Takano OA, Robazzi T, Alcantara C, Francescantonio I, Frèmond M-L, Kalil Filho JE. What is needed to diagnose an autoinflammatory disease? From clinical manifestations to genomic sequencing: the Brazilian experience [Internet]. Clinical Immunology. 2024 ; 262 51-52.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2024.110132
Artigo de periodico
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production (2023)
Córneo, Emily S.; Veras, Flávio Protásio ; Gomes, Giovanni F.; Schneider, Ayda Henriques ; Silva, Bruna Manuella Souza; Almeida, Cícero José Luíz dos Ramos; Silva, Camila M.; Martins, Ronaldo B.; Batah, Sabrina Setembre ; Simon, Carla S.; Prestes, Gabriele da S.; Alves Filho, José Carlos Farias ; Arruda, Eurico ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti Ribeiro de; Fabro, Alexandre Todorovic ; Cunha, Thiago Mattar ; Cunha, Fernando de Queiroz ; Dal-Pizzol, Felipe
Source: Clinical Immunology. Unidades: FMRP, ESALQ
Subjects: COVID-19, NEUTRÓFILOS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÓRNEO, Emily S. et al. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, v. 257, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2023.109836. Acesso em: 01 jul. 2025.
APA
Córneo, E. S., Veras, F. P., Gomes, G. F., Schneider, A. H., Silva, B. M. S., Almeida, C. J. L. dos R., et al. (2023). Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, 257, 1-12. doi:10.1016/j.clim.2023.109836
NLM
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Vancouver
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Artigo de periodico
In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: a brazilian cooperation (2022)
Mendonça, Leonardo Oliveira ; Barros, Myrthes Anna Maragna Toledo ; Leal, Vinicius Nunes Cordeiro ; Roa, Mariela Estefany Gislene Vera ; Cambuí, Raylane Adrielle Gonçalves ; Grumach, Anete Sevciovic ; Castro, Fabio Fernandes Morato ; Kalil Filho, Jorge Elias ; Pontillo, Alessandra
Source: Clinical Immunology. Unidades: FM, ICB
Subjects: IMUNOLOGIA, DOENÇAS GENÉTICAS, DOENÇAS AUTOIMUNES, ANORMALIDADES CONGÊNITAS, CITOCINAS, VARIAÇÃO GENÉTICA, INFLAMAÇÃO, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENDONÇA, Leonardo Oliveira et al. In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: a brazilian cooperation. Clinical Immunology, v. 245, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2022.109159. Acesso em: 01 jul. 2025.
APA
Mendonça, L. O., Barros, M. A. M. T., Leal, V. N. C., Roa, M. E. G. V., Cambuí, R. A. G., Grumach, A. S., et al. (2022). In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: a brazilian cooperation. Clinical Immunology, 245, 1-8. doi:10.1016/j.clim.2022.109159
NLM
Mendonça LO, Barros MAMT, Leal VNC, Roa MEGV, Cambuí RAG, Grumach AS, Castro FFM, Kalil Filho JE, Pontillo A. In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: a brazilian cooperation [Internet]. Clinical Immunology. 2022 ; 245 1-8.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2022.109159
Vancouver
Mendonça LO, Barros MAMT, Leal VNC, Roa MEGV, Cambuí RAG, Grumach AS, Castro FFM, Kalil Filho JE, Pontillo A. In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: a brazilian cooperation [Internet]. Clinical Immunology. 2022 ; 245 1-8.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2022.109159
Artigo de periodico
Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden (2022)
Anderson, John T. ; Cowan, Juthaporn ; Condino Neto, Antonio ; Levy, Donald; Prusty, Subhransu
Source: Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, QUALIDADE DE VIDA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDERSON, John T. et al. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clinical Immunology, v. 236, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2022.108931. Acesso em: 01 jul. 2025.
APA
Anderson, J. T., Cowan, J., Condino Neto, A., Levy, D., & Prusty, S. (2022). Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clinical Immunology, 236, 1-10. doi:10.1016/j.clim.2022.108931
NLM
Anderson JT, Cowan J, Condino Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden [Internet]. Clinical Immunology. 2022 ; 236 1-10.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2022.108931
Vancouver
Anderson JT, Cowan J, Condino Neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden [Internet]. Clinical Immunology. 2022 ; 236 1-10.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2022.108931
Artigo de periodico-carta/editorial
Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. (2021)
Santos, Isabel Kinney Ferreira de Miranda ; Cardoso, Cristina Ribeiro de Barros
Source: Clinical Immunology. Unidades: FMRP, FCFRP
Subjects: COVID-19, ATIVAÇÃO DE COMPLEMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Isabel Kinney Ferreira de Miranda e CARDOSO, Cristina Ribeiro de Barros. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clim.2020.108618. Acesso em: 01 jul. 2025. , 2021
APA
Santos, I. K. F. de M., & Cardoso, C. R. de B. (2021). Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.clim.2020.108618
NLM
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Vancouver
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Artigo de periodico-carta/editorial
Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. (2021)
Santos, Isabel Kinney Ferreira de Miranda ; Cardoso, Cristina Ribeiro de Barros
Source: Clinical Immunology. Unidades: FMRP, FCFRP
Subjects: COVID-19, DIAGNÓSTICO CLÍNICO, BIOLOGIA (ESTUDOS ESPECÍFICOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Isabel Kinney Ferreira de Miranda e CARDOSO, Cristina Ribeiro de Barros. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clim.2020.108618. Acesso em: 01 jul. 2025. , 2021
APA
Santos, I. K. F. de M., & Cardoso, C. R. de B. (2021). Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Clinical Immunology. Maryland Heights: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.clim.2020.108618
NLM
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222 1.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Vancouver
Santos IKF de M, Cardoso CR de B. Commentary on “Complement C3 vs C5 inhibition in severe COVID-19 [Carta]: early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. [Internet]. Clinical Immunology. 2021 ; 222 1.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108618
Artigo de periodico
Double-edged sword of inflammasome genetics in colorectal cancer prognosis (2020)
Cambui, Raylane Adrielle Gonçalves ; Santo, Gilmar Ferreira do Espírito; Fernandes, Fernanda Pereira ; Leal, Vinicius Nunes Cordeiro ; Galera, Bianca Borsatto; Fávaro, Emerson Giuliano Palacio ; Rizzo, Leonardo Amorim; Elias, Rosa Maria ; Pontillo, Alessandra
Source: Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNOGENÉTICA, NEOPLASIAS DO COLON, CARCINOGÊNESE, POLIMORFISMO, INFLAMAÇÃO, CITOCINAS, GRANULÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMBUI, Raylane Adrielle Gonçalves et al. Double-edged sword of inflammasome genetics in colorectal cancer prognosis. Clinical Immunology, v. 213, p. 6 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2020.108373. Acesso em: 01 jul. 2025.
APA
Cambui, R. A. G., Santo, G. F. do E., Fernandes, F. P., Leal, V. N. C., Galera, B. B., Fávaro, E. G. P., et al. (2020). Double-edged sword of inflammasome genetics in colorectal cancer prognosis. Clinical Immunology, 213, 6 . doi:10.1016/j.clim.2020.108373
NLM
Cambui RAG, Santo GF do E, Fernandes FP, Leal VNC, Galera BB, Fávaro EGP, Rizzo LA, Elias RM, Pontillo A. Double-edged sword of inflammasome genetics in colorectal cancer prognosis [Internet]. Clinical Immunology. 2020 ; 213 6 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108373
Vancouver
Cambui RAG, Santo GF do E, Fernandes FP, Leal VNC, Galera BB, Fávaro EGP, Rizzo LA, Elias RM, Pontillo A. Double-edged sword of inflammasome genetics in colorectal cancer prognosis [Internet]. Clinical Immunology. 2020 ; 213 6 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108373
Artigo de periodico
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy (2020)
Mastellos, Dimitrios C.; Silva, Bruno Garcia Peixoto Pires da; Fonseca, Benedito Antonio Lopes da; Fonseca, Natasha Peixoto; Martins, Maria Auxiliadora; Mastaglio, Sara; Ruggeri, Annalisa; Sironi, Marina; Radermacher, Peter; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos; Manfra, Ilenia; Iacobelli, Simona; Huber-Lang, Markus; Nilsson, Bo; Yancopoulou, Despina; Connolly, E. Sander; Garlanda, Cecilia; Ciceri, Fabio; Risitano, Antonio M.; Calado, Rodrigo Tocantins; Lambris, John D.
Source: Clinical Immunology. Unidade: FMRP
Subjects: COVID-19, TROMBOSE, FÁRMACOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASTELLOS, Dimitrios C. et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, v. 220, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2020.108598. Acesso em: 01 jul. 2025.
APA
Mastellos, D. C., Silva, B. G. P. P. da, Fonseca, B. A. L. da, Fonseca, N. P., Martins, M. A., Mastaglio, S., et al. (2020). Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, 220. doi:10.1016/j.clim.2020.108598
NLM
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Vancouver
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Artigo de periodico
Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection (2019)
Reis, Edione Cristina dos; Leal, Vinicius Nunes Cordeiro ; Silva, Laís Teodoro da; Reis, Marília Masson Loureiro dos; Argañaraz, Enrique Roberto; Sumida, Telma Miyuki Oshiro; Pontillo, Alessandra
Source: Clinical Immunology. Unidades: ICB, FM
Subjects: IMUNOLOGIA, ANTAGONISTAS, INFECÇÕES POR HIV, POLIMORFISMO, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, IMUNOTERAPIA, CÉLULAS DENDRÍTICAS, VARIAÇÃO GENÉTICA, PROLIFERAÇÃO CELULAR, POLIPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, Edione Cristina dos et al. Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection. Clinical Immunology, v. 209, p. 10 , 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2019.108266. Acesso em: 01 jul. 2025.
APA
Reis, E. C. dos, Leal, V. N. C., Silva, L. T. da, Reis, M. M. L. dos, Argañaraz, E. R., Sumida, T. M. O., & Pontillo, A. (2019). Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection. Clinical Immunology, 209, 10 . doi:10.1016/j.clim.2019.108266
NLM
Reis EC dos, Leal VNC, Silva LT da, Reis MML dos, Argañaraz ER, Sumida TMO, Pontillo A. Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection [Internet]. Clinical Immunology. 2019 ; 209 10 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2019.108266
Vancouver
Reis EC dos, Leal VNC, Silva LT da, Reis MML dos, Argañaraz ER, Sumida TMO, Pontillo A. Antagonistic role of IL-1ß and NLRP3/IL-18 genetics in chronic HIV-1 infection [Internet]. Clinical Immunology. 2019 ; 209 10 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2019.108266
Artigo de periodico
Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic (2018)
Soares, Jaine L. S.; Fernandes, Fernanda Pereira; Patente, Thiago Andrade; Monteiro, Maria B.; Parisi, Maria C.; Giannella-Neto, Daniel; Corrêa-Giannella, Maria L.; Pontillo, Alessandra
Source: Clinical Immunology. Unidades: FM, ICB
Subjects: NEFROPATIAS, METABÓLITOS, POLÍMEROS (QUÍMICA ORGÂNICA), INSUFICIÊNCIA RENAL, DIABETES MELLITUS, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Jaine L. S. et al. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic. Clinical Immunology, v. 187, p. 46-49, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2017.10.003. Acesso em: 01 jul. 2025.
APA
Soares, J. L. S., Fernandes, F. P., Patente, T. A., Monteiro, M. B., Parisi, M. C., Giannella-Neto, D., et al. (2018). Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic. Clinical Immunology, 187, 46-49. doi:10.1016/j.clim.2017.10.003
NLM
Soares JLS, Fernandes FP, Patente TA, Monteiro MB, Parisi MC, Giannella-Neto D, Corrêa-Giannella ML, Pontillo A. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic [Internet]. Clinical Immunology. 2018 ; 187 46-49.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2017.10.003
Vancouver
Soares JLS, Fernandes FP, Patente TA, Monteiro MB, Parisi MC, Giannella-Neto D, Corrêa-Giannella ML, Pontillo A. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney diseases: NLRP1 inflammasome role in metabolic [Internet]. Clinical Immunology. 2018 ; 187 46-49.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2017.10.003
Artigo de periodico
The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing (2018)
Guimarães, Francielle Rodrigues; Sales-Campos, Helioswilton; Nardini, Viviani; Costa, Thiago Alvares da; Fonseca, Monique Thaís Costa; Rodrigues Júnior, Virmondes; Sorgi, Carlos Arterio; Silva, João Santana da; Chica, Javier Emílio Lazo; Faccioli, Lucia Helena; Cardoso, Cristina Ribeiro de Barros
Source: Clinical Immunology. Unidades: FCFRP, FMRP
Subjects: LEUCOTRIENOS, INFLAMAÇÃO, PELE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Francielle Rodrigues et al. The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing. Clinical Immunology, v. 190, p. 74-83, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2017.08.022. Acesso em: 01 jul. 2025.
APA
Guimarães, F. R., Sales-Campos, H., Nardini, V., Costa, T. A. da, Fonseca, M. T. C., Rodrigues Júnior, V., et al. (2018). The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing. Clinical Immunology, 190, 74-83. doi:10.1016/j.clim.2017.08.022
NLM
Guimarães FR, Sales-Campos H, Nardini V, Costa TA da, Fonseca MTC, Rodrigues Júnior V, Sorgi CA, Silva JS da, Chica JEL, Faccioli LH, Cardoso CR de B. The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing [Internet]. Clinical Immunology. 2018 ; 190 74-83.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2017.08.022
Vancouver
Guimarães FR, Sales-Campos H, Nardini V, Costa TA da, Fonseca MTC, Rodrigues Júnior V, Sorgi CA, Silva JS da, Chica JEL, Faccioli LH, Cardoso CR de B. The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB 4 ) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing [Internet]. Clinical Immunology. 2018 ; 190 74-83.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2017.08.022
Artigo de periodico
Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation (2016)
Arruda, Lucas C. M.; Azevedo, Júlia T. C. de; Oliveira, Gislaine L. V. de; Scortegagna, Gabriela T.; Rodrigues, Evandra S.; Palma, Patrícia V. B.; Brum, Doralina G.; Guerreiro, Carlos T.; Marques, Vanessa D.; Barreira, Amilton Antunes; Covas, Dimas Tadeu; Simões, Belinda Pinto; Voltarelli, Júlio César; Oliveira, Maria Carolina; Malmegrim, Kelen C. R.
Source: Clinical Immunology. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA, LINFÓCITOS T, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas C. M. et al. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation. Clinical Immunology, v. 169, p. 47-57, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2016.06.005. Acesso em: 01 jul. 2025.
APA
Arruda, L. C. M., Azevedo, J. T. C. de, Oliveira, G. L. V. de, Scortegagna, G. T., Rodrigues, E. S., Palma, P. V. B., et al. (2016). Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation. Clinical Immunology, 169, 47-57. doi:10.1016/j.clim.2016.06.005
NLM
Arruda LCM, Azevedo JTC de, Oliveira GLV de, Scortegagna GT, Rodrigues ES, Palma PVB, Brum DG, Guerreiro CT, Marques VD, Barreira AA, Covas DT, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KCR. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Clinical Immunology. 2016 ; 169 47-57.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2016.06.005
Vancouver
Arruda LCM, Azevedo JTC de, Oliveira GLV de, Scortegagna GT, Rodrigues ES, Palma PVB, Brum DG, Guerreiro CT, Marques VD, Barreira AA, Covas DT, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KCR. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Clinical Immunology. 2016 ; 169 47-57.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2016.06.005
Artigo de periodico
Fetal-onset IPEX: Report of two families and review of literature (2015)
Xavier da Silva, Mariana Moraes; Moreira-Filho, Carlos A.; Suzuki, Edson; Patricio, Francy; Coutinho, Antonio; Sampaio, Magda Carneiro
Source: Clinical Immunology. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, FETO (ANOMALIAS;CRESCIMENTO E DESENVOLVIMENTO), DOENÇAS AUTOIMUNES, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XAVIER DA SILVA, Mariana Moraes et al. Fetal-onset IPEX: Report of two families and review of literature. Clinical Immunology, v. 156, p. 131-140, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2014.12.007. Acesso em: 01 jul. 2025.
APA
Xavier da Silva, M. M., Moreira-Filho, C. A., Suzuki, E., Patricio, F., Coutinho, A., & Sampaio, M. C. (2015). Fetal-onset IPEX: Report of two families and review of literature. Clinical Immunology, 156, 131-140. doi:10.1016/j.clim.2014.12.007
NLM
Xavier da Silva MM, Moreira-Filho CA, Suzuki E, Patricio F, Coutinho A, Sampaio MC. Fetal-onset IPEX: Report of two families and review of literature [Internet]. Clinical Immunology. 2015 ; 156 131-140.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2014.12.007
Vancouver
Xavier da Silva MM, Moreira-Filho CA, Suzuki E, Patricio F, Coutinho A, Sampaio MC. Fetal-onset IPEX: Report of two families and review of literature [Internet]. Clinical Immunology. 2015 ; 156 131-140.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2014.12.007
Artigo de periodico
NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene (2014)
Torres, Leuridan Cavalcante; Soares, Diogo C. de Queiroz; Kulikowski, Leslie D.; Franco, Jose Francisco; Kim, Chong Ae
Source: Clinical Immunology. Unidade: FM
Subjects: LINFÓCITOS B, GLICOSAMINOGLICANAS, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORRES, Leuridan Cavalcante et al. NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene. Clinical Immunology, v. 154, p. 100-104, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2014.07.001. Acesso em: 01 jul. 2025.
APA
Torres, L. C., Soares, D. C. de Q., Kulikowski, L. D., Franco, J. F., & Kim, C. A. (2014). NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene. Clinical Immunology, 154, 100-104. doi:10.1016/j.clim.2014.07.001
NLM
Torres LC, Soares DC de Q, Kulikowski LD, Franco JF, Kim CA. NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene [Internet]. Clinical Immunology. 2014 ; 154 100-104.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2014.07.001
Vancouver
Torres LC, Soares DC de Q, Kulikowski LD, Franco JF, Kim CA. NK and B cell deficiency in a MPS type II family with novel mutation in the IDS gene [Internet]. Clinical Immunology. 2014 ; 154 100-104.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2014.07.001
Trabalho de evento-resumo periodico
The awareness of pediatricians concerning primary immunodeficiency diseases in Brazil before and after an education program (2010)
Dantas, E. O.; Silva, A. R.; Tavares, F. S.; Takano, O. A.; Toledo, E.; Barreto, I. P.; Wandalsen, N. F.; Damasceno, E.; Aranda, C. S.; Nobre, F. A.; Félix, E.; Roxo Junior, P.; Quadros Coelho, M. A.; Segundo, G. S.; Pinto, J. A.; Porto, A.; Schisler, K. L.; Sousa Vieira, H. C.; Friedenbach, D. L.; Condino Neto, Antonio; Nudelman, V.; Sales, V.; Silva, M. R.; Goudoris, E. S.; Costa Carvalho, B. T.
Source: Clinical Immunology. Conference titles: North American Primary Immune Deficiency National Conference. Unidades: ICB, FMRP
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, E. O. et al. The awareness of pediatricians concerning primary immunodeficiency diseases in Brazil before and after an education program. Clinical Immunology. Philadelphia: Clinical Immunology Society. . Acesso em: 01 jul. 2025. , 2010
APA
Dantas, E. O., Silva, A. R., Tavares, F. S., Takano, O. A., Toledo, E., Barreto, I. P., et al. (2010). The awareness of pediatricians concerning primary immunodeficiency diseases in Brazil before and after an education program. Clinical Immunology. Philadelphia: Clinical Immunology Society.
NLM
Dantas EO, Silva AR, Tavares FS, Takano OA, Toledo E, Barreto IP, Wandalsen NF, Damasceno E, Aranda CS, Nobre FA, Félix E, Roxo Junior P, Quadros Coelho MA, Segundo GS, Pinto JA, Porto A, Schisler KL, Sousa Vieira HC, Friedenbach DL, Condino Neto A, Nudelman V, Sales V, Silva MR, Goudoris ES, Costa Carvalho BT. The awareness of pediatricians concerning primary immunodeficiency diseases in Brazil before and after an education program. Clinical Immunology. 2010 ; 135( 2): 302.[citado 2025 jul. 01 ]
Vancouver
Dantas EO, Silva AR, Tavares FS, Takano OA, Toledo E, Barreto IP, Wandalsen NF, Damasceno E, Aranda CS, Nobre FA, Félix E, Roxo Junior P, Quadros Coelho MA, Segundo GS, Pinto JA, Porto A, Schisler KL, Sousa Vieira HC, Friedenbach DL, Condino Neto A, Nudelman V, Sales V, Silva MR, Goudoris ES, Costa Carvalho BT. The awareness of pediatricians concerning primary immunodeficiency diseases in Brazil before and after an education program. Clinical Immunology. 2010 ; 135( 2): 302.[citado 2025 jul. 01 ]
Trabalho de evento-resumo periodico
Neutrophils and monocytes from patients with CD40L deficiency present a defective respiratory burst response to several stimuli and this defect can be reversed by exogenous IFN-Gamma (2010)
Marques, O. C.; Frazão, J.; Pereira, P.; Kubo, C.; Falcai, A.; Klaver, S.; Errante, P.; Fernandes, J.; Weber, C.; Rosario-Filho, N.; Carvalho, B.; Condino-Neto, Antonio
Source: Clinical Immunology. Conference titles: North American Primary Immune Deficiency National Conference. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, O. C. et al. Neutrophils and monocytes from patients with CD40L deficiency present a defective respiratory burst response to several stimuli and this defect can be reversed by exogenous IFN-Gamma. Clinical Immunology. Philadelphia: Clinical Immunology Society. . Acesso em: 01 jul. 2025. , 2010
APA
Marques, O. C., Frazão, J., Pereira, P., Kubo, C., Falcai, A., Klaver, S., et al. (2010). Neutrophils and monocytes from patients with CD40L deficiency present a defective respiratory burst response to several stimuli and this defect can be reversed by exogenous IFN-Gamma. Clinical Immunology. Philadelphia: Clinical Immunology Society.
NLM
Marques OC, Frazão J, Pereira P, Kubo C, Falcai A, Klaver S, Errante P, Fernandes J, Weber C, Rosario-Filho N, Carvalho B, Condino-Neto A. Neutrophils and monocytes from patients with CD40L deficiency present a defective respiratory burst response to several stimuli and this defect can be reversed by exogenous IFN-Gamma. Clinical Immunology. 2010 ; 135( 2): 296.[citado 2025 jul. 01 ]
Vancouver
Marques OC, Frazão J, Pereira P, Kubo C, Falcai A, Klaver S, Errante P, Fernandes J, Weber C, Rosario-Filho N, Carvalho B, Condino-Neto A. Neutrophils and monocytes from patients with CD40L deficiency present a defective respiratory burst response to several stimuli and this defect can be reversed by exogenous IFN-Gamma. Clinical Immunology. 2010 ; 135( 2): 296.[citado 2025 jul. 01 ]
Trabalho de evento-resumo periodico
IFN-γ strongly increases the expression of SSA/Ro and Sm-RNP spliciosome proteins in leukocytes from X-linked chronic granulomatous disease (CGD) patients and normal controls (2010)
Frazão, Josias; Oliveira, Edgar; Rodrigues, Silvia; Aragão-Filho, Walmir; Redher, Jussara; Costa-Carvalho, Beatriz; Andrade, Luis Eduardo; Condino-Neto, Antonio
Source: Clinical Immunology. Conference titles: Annual Meeting, Federation of Clinical Immunology Societies. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAZÃO, Josias et al. IFN-γ strongly increases the expression of SSA/Ro and Sm-RNP spliciosome proteins in leukocytes from X-linked chronic granulomatous disease (CGD) patients and normal controls. Clinical Immunology. Boston: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clim.2010.03.271. Acesso em: 01 jul. 2025. , 2010
APA
Frazão, J., Oliveira, E., Rodrigues, S., Aragão-Filho, W., Redher, J., Costa-Carvalho, B., et al. (2010). IFN-γ strongly increases the expression of SSA/Ro and Sm-RNP spliciosome proteins in leukocytes from X-linked chronic granulomatous disease (CGD) patients and normal controls. Clinical Immunology. Boston: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.clim.2010.03.271
NLM
Frazão J, Oliveira E, Rodrigues S, Aragão-Filho W, Redher J, Costa-Carvalho B, Andrade LE, Condino-Neto A. IFN-γ strongly increases the expression of SSA/Ro and Sm-RNP spliciosome proteins in leukocytes from X-linked chronic granulomatous disease (CGD) patients and normal controls [Internet]. Clinical Immunology. 2010 ; 135 S90.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2010.03.271
Vancouver
Frazão J, Oliveira E, Rodrigues S, Aragão-Filho W, Redher J, Costa-Carvalho B, Andrade LE, Condino-Neto A. IFN-γ strongly increases the expression of SSA/Ro and Sm-RNP spliciosome proteins in leukocytes from X-linked chronic granulomatous disease (CGD) patients and normal controls [Internet]. Clinical Immunology. 2010 ; 135 S90.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2010.03.271
Trabalho de evento-resumo periodico
The role of SSCP versus DHPLC techniques in mutation sof CYBB gene: report of two new mutations (2010)
Oliveira, E. B. de; Prando, C.; Lopez, J. A.; Arango, J. C.; Buzolin, M.; Yajima, J.; Uyeda, T.; Rehder, J.; Formighieri, E.; Pedroza, L. A.; Frazão, J. B.; Condino Neto, Antonio
Source: Clinical Immunology. Conference titles: North American Primary Immune Deficiency National Conference. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, E. B. de et al. The role of SSCP versus DHPLC techniques in mutation sof CYBB gene: report of two new mutations. Clinical Immunology. Philadelphia: Clinical Immunology Society. . Acesso em: 01 jul. 2025. , 2010
APA
Oliveira, E. B. de, Prando, C., Lopez, J. A., Arango, J. C., Buzolin, M., Yajima, J., et al. (2010). The role of SSCP versus DHPLC techniques in mutation sof CYBB gene: report of two new mutations. Clinical Immunology. Philadelphia: Clinical Immunology Society.
NLM
Oliveira EB de, Prando C, Lopez JA, Arango JC, Buzolin M, Yajima J, Uyeda T, Rehder J, Formighieri E, Pedroza LA, Frazão JB, Condino Neto A. The role of SSCP versus DHPLC techniques in mutation sof CYBB gene: report of two new mutations. Clinical Immunology. 2010 ; 135( 2): 327.[citado 2025 jul. 01 ]
Vancouver
Oliveira EB de, Prando C, Lopez JA, Arango JC, Buzolin M, Yajima J, Uyeda T, Rehder J, Formighieri E, Pedroza LA, Frazão JB, Condino Neto A. The role of SSCP versus DHPLC techniques in mutation sof CYBB gene: report of two new mutations. Clinical Immunology. 2010 ; 135( 2): 327.[citado 2025 jul. 01 ]
Trabalho de evento-resumo periodico
Suppression of experimental autoimmune uveitis by FTY720 (2010)
Commodaro, Alessandra; Pedregosa, Juliana; Peron, Jean Pierre Schatzmann ; Belfort Junior, Rubens; Rizzo, Luiz Vicente; Bueno, Valquiria
Source: Clinical Immunology. Conference titles: Annual Meeting, Federation of Clinical Immunology Societies. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMMODARO, Alessandra et al. Suppression of experimental autoimmune uveitis by FTY720. Clinical Immunology. Boston: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.clim.2010.03.222. Acesso em: 01 jul. 2025. , 2010
APA
Commodaro, A., Pedregosa, J., Peron, J. P. S., Belfort Junior, R., Rizzo, L. V., & Bueno, V. (2010). Suppression of experimental autoimmune uveitis by FTY720. Clinical Immunology. Boston: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.clim.2010.03.222
NLM
Commodaro A, Pedregosa J, Peron JPS, Belfort Junior R, Rizzo LV, Bueno V. Suppression of experimental autoimmune uveitis by FTY720 [Internet]. Clinical Immunology. 2010 ; 135 S73.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2010.03.222
Vancouver
Commodaro A, Pedregosa J, Peron JPS, Belfort Junior R, Rizzo LV, Bueno V. Suppression of experimental autoimmune uveitis by FTY720 [Internet]. Clinical Immunology. 2010 ; 135 S73.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.clim.2010.03.222

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration